Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 15, 2022

BUY
$144.95 - $152.29 $2.72 Million - $2.86 Million
18,782 Added 1.08%
1,763,828 $267 Million
Q2 2022

Aug 15, 2022

BUY
$83.14 - $145.99 $7.42 Million - $13 Million
89,212 Added 5.39%
1,745,046 $254 Million
Q1 2022

May 16, 2022

BUY
$110.08 - $142.92 $896,051 - $1.16 Million
8,140 Added 0.49%
1,655,834 $196 Million
Q4 2021

Feb 14, 2022

BUY
$99.73 - $148.48 $16.2 Million - $24.2 Million
162,764 Added 10.96%
1,647,694 $227 Million
Q3 2021

Nov 15, 2021

BUY
$98.85 - $138.91 $431,282 - $606,064
4,363 Added 0.29%
1,484,930 $206 Million
Q2 2021

Aug 16, 2021

SELL
$65.78 - $105.02 $3.56 Million - $5.69 Million
-54,177 Reduced 3.53%
1,480,567 $144 Million
Q1 2021

May 17, 2021

SELL
$64.07 - $91.75 $8.79 Million - $12.6 Million
-137,205 Reduced 8.21%
1,534,744 $105 Million
Q4 2020

Feb 16, 2021

SELL
$65.07 - $98.24 $6.59 Million - $9.94 Million
-101,223 Reduced 5.71%
1,671,949 $143 Million
Q3 2020

Nov 10, 2020

BUY
$59.04 - $77.95 $145,415 - $191,990
2,463 Added 0.14%
1,773,172 $115 Million
Q2 2020

Aug 14, 2020

SELL
$29.01 - $74.23 $5.95 Million - $15.2 Million
-205,232 Reduced 10.39%
1,770,709 $129 Million
Q1 2020

May 11, 2020

BUY
$27.51 - $57.29 $54.4 Million - $113 Million
1,975,941 New
1,975,941 $67.2 Million

Others Institutions Holding BHVN

About Biohaven Pharmaceutical Holding Co Ltd.


  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $3.18B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.